TransMedics Group Sees FY24 Revenue $425M-$445M Vs $444.36M Est.
Portfolio Pulse from Benzinga Newsdesk
TransMedics Group projects its FY24 revenue to be between $425M and $445M, indicating a 76% to 84% growth from the previous year. This range is slightly below the market estimate of $444.36M.
October 28, 2024 | 8:10 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
TransMedics Group's FY24 revenue forecast of $425M-$445M suggests strong growth but is slightly below market expectations of $444.36M.
The revenue forecast indicates significant growth, which is positive. However, the upper range of the forecast is only slightly above the market estimate, which may lead to a neutral short-term impact on the stock price as the market had anticipated similar figures.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100